New advances in inclusion-body myositis

Curr Opin Rheumatol. 1993 Nov;5(6):732-41. doi: 10.1097/00002281-199305060-00007.

Abstract

The major new advances in seeking the pathogenic mechanisms of sporadic inclusion-body myositis and hereditary inclusion-body myopathy are discussed. Hypotheses are presented regarding the possible causes and significance of amyloid deposits in sporadic inclusion-body myositis and the roles of abnormally accumulated ubiquitin, beta-amyloid protein, beta-amyloid precursor protein, alpha 1-antichymotrypsin, hyperphosphorylated tau, and prion protein in the vacuolated muscle fibers in both sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Because hereditary inclusion-body myopathy is virtually free of Congophilic amyloid deposits but, like sporadic inclusion-body myositis, contains large accumulations of beta-amyloid protein, it is possible that the lesions in hereditary inclusion-body myopathy may represent "early" changes. There are striking similarities between the pathology of inclusion-body myositis muscle and brains affected by Alzheimer's disease in regard to accumulation of ubiquitin, beta-amyloid protein and its precursor protein, alpha 1-antichymotrypsin, and hyperphosphorylated tau.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amyloid / analysis
  • Humans
  • Inclusion Bodies / chemistry*
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Muscles / ultrastructure
  • Polymyositis / complications
  • Polymyositis / genetics
  • Polymyositis / pathology*
  • Ubiquitins / analysis
  • alpha 1-Antichymotrypsin / analysis

Substances

  • Amyloid
  • Ubiquitins
  • alpha 1-Antichymotrypsin